ID   MHHi008-B
AC   CVCL_VS39
SY   CD34+hPBHSC_GMPDU_SeV-iPS16
DR   hPSCreg; MHHi008-B
DR   Wikidata; Q95989474
RX   PubMed=30772682;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30772682
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS38 ! MHHi008-A
OI   CVCL_VS40 ! MHHi008-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=30772682; DOI=10.1016/j.scr.2019.101394;
RA   Haase A., Glienke W., Engels L., Gohring G., Esser R., Arseniev L.,
RA   Martin U.;
RT   "GMP-compatible manufacturing of three iPS cell lines from human
RT   peripheral blood.";
RL   Stem Cell Res. 35:101394-101394(2019).
//